Process of diseased tau assembly into neurofibrillary structures differs in Alzheimer's disease and other tauopathies

被引：0
|
作者：
Zilkova, M
Vechterova, L
Konstekova, E
Konstek, P
Novak, M
机构：
[1] Inst Neuroimmunol, Bratislava, Slovakia
[2] Axon Neurosci, Vienna, Austria
来源：
NEUROBIOLOGY OF AGING | 2004年 / 25卷
关键词：
D O I：
10.1016/S0197-4580(04)81384-8
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页码：S421 / S421
页数：1
相关论文
共 50 条
  • [41] Tau phosphatases and neurofibrillary degeneration of Alzheimer disease
    Gong, C. X.
    Wang, J. Z.
    Pei, J. J.
    Grundke-Iqbal, I.
    Iqbal, K.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 48 - 48
  • [42] Immunological demonstration of tau protein in neurofibrillary tangles of Alzheimer's disease
    Brion, Jean-Pierre
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 : 177 - 185
  • [43] Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease
    Guillozet-Bongaarts, AL
    Garcia-Sierra, F
    Reynolds, MR
    Horowitz, PM
    Fu, YF
    Wang, TY
    Cahill, ME
    Bigio, EH
    Berry, RW
    Binder, LI
    NEUROBIOLOGY OF AGING, 2005, 26 (07) : 1015 - 1022
  • [44] Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer’s disease and not in other tauopathies
    Geoffrey Pires
    Sacha McElligott
    Shiron Drusinsky
    Glenda Halliday
    Marie-Claude Potier
    Thomas Wisniewski
    Eleanor Drummond
    Acta Neuropathologica Communications, 7
  • [45] Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer's disease and primary tauopathies
    de Ruyter, Frederique Hart J.
    Morrema, Tjado H. J.
    den Haan, Jurre
    Twisk, Jos W. R.
    de Boer, Johannes F.
    Scheltens, Philip
    Boon, Baayla D. C.
    Thal, Dietmar R.
    Rozemuller, Annemieke J.
    Verbraak, Frank D.
    Bouwman, Femke H.
    Hoozemans, Jeroen J. M.
    Netherlands Brain Bank
    ACTA NEUROPATHOLOGICA, 2022, 145 (2) : 197 - 218
  • [46] Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer’s disease and primary tauopathies
    Frederique J. Hart de Ruyter
    Tjado H. J. Morrema
    Jurre den Haan
    Jos W. R. Twisk
    Johannes F. de Boer
    Philip Scheltens
    Baayla D. C. Boon
    Dietmar R. Thal
    Annemieke J. Rozemuller
    Frank D. Verbraak
    Femke H. Bouwman
    Jeroen J. M. Hoozemans
    Acta Neuropathologica, 2023, 145 : 197 - 218
  • [47] A novel peptide-based tau aggregation inhibitor as a potential therapeutic for Alzheimer's disease and other tauopathies
    Aggidis, Anthony
    Devitt, George
    Zhang, Yongrui
    Chatterjee, Shreyasi
    Townsend, David
    Fullwood, Nigel J.
    Ortega, Eva Ruiz
    Tarutani, Airi
    Hasegawa, Masato
    Cooper, Amber
    Williamson, Philip
    Mendoza-Oliva, Ayde
    Diamond, Marc I.
    Mudher, Amritpal
    Allsop, David
    ALZHEIMERS & DEMENTIA, 2024, 20 (11) : 7788 - 7804
  • [48] Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies
    Pires, Geoffrey
    McElligott, Sacha
    Drusinsky, Shiron
    Halliday, Glenda
    Potier, Marie-Claude
    Wisniewski, Thomas
    Drummond, Eleanor
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [49] Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
    John Q Trojanowski
    Molecular Neurodegeneration, 8 (Suppl 1)
  • [50] Current strategies for the treatment of Alzheimer's disease and other tauopathies
    Dickey, Chad A.
    Petrucelli, Leonard
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (05) : 665 - 676
12345